 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that PTGX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Protagonist Therapeutics (PTGX, $16.7) RSI Indicator left the oversold zone on September 29, 2023

For the last three days, A.I.dvisor has detected that PTGX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Protagonist Therapeutics (PTGX, $16.7) Aroon Indicator entered a Downtrend on September 29, 2023.

Protagonist Therapeutics (PTGX, $17.13) Aroon Indicator entered a Downtrend on September 28, 2023.

Protagonist Therapeutics (PTGX, $17.57) Aroon Indicator entered a Downtrend on September 27, 2023.

Protagonist Therapeutics (PTGX, $17.49) Aroon Indicator entered a Downtrend on September 26, 2023.

Protagonist Therapeutics (NASDAQ:PTGX  Free Report) had its target price cut by JPMorgan Chase  Co. from $36.00 to $34.00 in a research note released on Monday morning, Marketbeat...

JPMorgan Chase & Co. Lowers Protagonist Therapeutics (NASDAQ:PTGX) Price Target to $34.00

Protagonist Therapeutics (PTGX, $17.19) Aroon Indicator entered a Downtrend on September 25, 2023.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX  Get Free Report) shares fell 3.9% during mid-day trading on Monday after JPMorgan Chase  Co. lowered their price target on the stock from...

Protagonist Therapeutics (NASDAQ:PTGX) Stock Price Down 3.9% After Analyst Downgrade

StockNews.com upgraded shares of Protagonist Therapeutics (NASDAQ:PTGX  Free Report) from a sell rating to a hold rating in a research report sent to investors on Friday morning. Several other...

Protagonist Therapeutics (NASDAQ:PTGX) Lifted to "Hold" at StockNews.com

Protagonist Therapeutics (PTGX, $17.11) Aroon Indicator entered a Downtrend on September 22, 2023.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Watchers	3,296
52-Wk Low	$7.24
52-Wk High	$30.10

Market Cap	$959.6M
Volume (M)	1.39M
52-Wk High	$30.10
52-Wk Low	$7.24

PTGX Protagonist Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals